

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proteasome assembly (GO:0043248) | 5.39910974 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.00405283 |
| 3 | chaperone-mediated protein transport (GO:0072321) | 4.69867724 |
| 4 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.62528084 |
| 5 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.37732542 |
| 6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.37651592 |
| 7 | ATP synthesis coupled proton transport (GO:0015986) | 4.37651592 |
| 8 | protein neddylation (GO:0045116) | 4.10974958 |
| 9 | cullin deneddylation (GO:0010388) | 4.10796931 |
| 10 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.08325211 |
| 11 | peptidyl-histidine modification (GO:0018202) | 4.05815646 |
| 12 | protein targeting to mitochondrion (GO:0006626) | 4.05426845 |
| 13 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.04949061 |
| 14 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.03545518 |
| 15 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.02336845 |
| 16 | negative regulation of ligase activity (GO:0051352) | 4.02336845 |
| 17 | iron-sulfur cluster assembly (GO:0016226) | 3.95965902 |
| 18 | metallo-sulfur cluster assembly (GO:0031163) | 3.95965902 |
| 19 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.93461282 |
| 20 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.89036750 |
| 21 | rRNA modification (GO:0000154) | 3.87454011 |
| 22 | protein deneddylation (GO:0000338) | 3.85254310 |
| 23 | pseudouridine synthesis (GO:0001522) | 3.82239304 |
| 24 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.81976732 |
| 25 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.81976732 |
| 26 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.81438445 |
| 27 | regulation of mitochondrial translation (GO:0070129) | 3.80754791 |
| 28 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.79858176 |
| 29 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.79858176 |
| 30 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.79858176 |
| 31 | establishment of protein localization to mitochondrion (GO:0072655) | 3.73323444 |
| 32 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.71514697 |
| 33 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.71514697 |
| 34 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.68343885 |
| 35 | protein complex biogenesis (GO:0070271) | 3.67973559 |
| 36 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.66886767 |
| 37 | protein localization to mitochondrion (GO:0070585) | 3.62107680 |
| 38 | spliceosomal snRNP assembly (GO:0000387) | 3.61848341 |
| 39 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.59498115 |
| 40 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.59444863 |
| 41 | respiratory electron transport chain (GO:0022904) | 3.54080501 |
| 42 | electron transport chain (GO:0022900) | 3.53639406 |
| 43 | ribosomal small subunit biogenesis (GO:0042274) | 3.50786984 |
| 44 | base-excision repair, AP site formation (GO:0006285) | 3.46789091 |
| 45 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.45464445 |
| 46 | positive regulation of ligase activity (GO:0051351) | 3.40843207 |
| 47 | respiratory chain complex IV assembly (GO:0008535) | 3.40195191 |
| 48 | ribosomal small subunit assembly (GO:0000028) | 3.37453969 |
| 49 | termination of RNA polymerase III transcription (GO:0006386) | 3.37356692 |
| 50 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.37356692 |
| 51 | ribosomal large subunit biogenesis (GO:0042273) | 3.34987907 |
| 52 | viral transcription (GO:0019083) | 3.32374662 |
| 53 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.30289765 |
| 54 | protein maturation by protein folding (GO:0022417) | 3.30150735 |
| 55 | GTP biosynthetic process (GO:0006183) | 3.28406195 |
| 56 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.27974649 |
| 57 | NADH dehydrogenase complex assembly (GO:0010257) | 3.27974649 |
| 58 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.27974649 |
| 59 | formation of translation preinitiation complex (GO:0001731) | 3.24548282 |
| 60 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.18610261 |
| 61 | translational elongation (GO:0006414) | 3.17888311 |
| 62 | translational termination (GO:0006415) | 3.17874288 |
| 63 | DNA damage response, detection of DNA damage (GO:0042769) | 3.17393462 |
| 64 | regulation of ligase activity (GO:0051340) | 3.15832053 |
| 65 | rRNA methylation (GO:0031167) | 3.14481035 |
| 66 | cytochrome complex assembly (GO:0017004) | 3.14440211 |
| 67 | translation (GO:0006412) | 3.12697314 |
| 68 | cotranslational protein targeting to membrane (GO:0006613) | 3.12035377 |
| 69 | protein targeting to ER (GO:0045047) | 3.11692371 |
| 70 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.11009201 |
| 71 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.11009201 |
| 72 | regulation of cellular amine metabolic process (GO:0033238) | 3.07233525 |
| 73 | cellular component biogenesis (GO:0044085) | 3.04983249 |
| 74 | CTP biosynthetic process (GO:0006241) | 3.03608689 |
| 75 | CTP metabolic process (GO:0046036) | 3.03608689 |
| 76 | UTP biosynthetic process (GO:0006228) | 3.03490289 |
| 77 | establishment of integrated proviral latency (GO:0075713) | 3.02881578 |
| 78 | positive regulation of cell cycle arrest (GO:0071158) | 3.02728825 |
| 79 | protein localization to endoplasmic reticulum (GO:0070972) | 3.00668026 |
| 80 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.98600596 |
| 81 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.97833236 |
| 82 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.97729189 |
| 83 | translational initiation (GO:0006413) | 2.94821076 |
| 84 | protein-cofactor linkage (GO:0018065) | 2.92368335 |
| 85 | oxidative phosphorylation (GO:0006119) | 2.91109283 |
| 86 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.91032368 |
| 87 | negative regulation of protein ubiquitination (GO:0031397) | 2.90194486 |
| 88 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.88905552 |
| 89 | DNA double-strand break processing (GO:0000729) | 2.88166396 |
| 90 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.86991507 |
| 91 | histone arginine methylation (GO:0034969) | 2.86865286 |
| 92 | GMP metabolic process (GO:0046037) | 2.85033329 |
| 93 | ribosome assembly (GO:0042255) | 2.82457125 |
| 94 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.81460209 |
| 95 | inner mitochondrial membrane organization (GO:0007007) | 2.80798906 |
| 96 | rRNA processing (GO:0006364) | 2.80303329 |
| 97 | 7-methylguanosine mRNA capping (GO:0006370) | 2.79826725 |
| 98 | IMP biosynthetic process (GO:0006188) | 2.79312350 |
| 99 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.78855286 |
| 100 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.78425120 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.81761593 |
| 2 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.27757669 |
| 3 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 4.22462458 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.05039033 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.89793160 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.71466161 |
| 7 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.70386272 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.63031750 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.62678041 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.37101593 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.32729277 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.06681635 |
| 13 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.96767918 |
| 14 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.87367039 |
| 15 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.57435259 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.56058265 |
| 17 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.55839493 |
| 18 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.52728011 |
| 19 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.47814466 |
| 20 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.40399991 |
| 21 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.35887188 |
| 22 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.30685096 |
| 23 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.30017059 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.28372795 |
| 25 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.26871986 |
| 26 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.22463453 |
| 27 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.20196122 |
| 28 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.08819641 |
| 29 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.08182704 |
| 30 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 2.02039278 |
| 31 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.99569470 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.91132675 |
| 33 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.83600456 |
| 34 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.82717123 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.65232485 |
| 36 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.64537448 |
| 37 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.62485039 |
| 38 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.59738978 |
| 39 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.58644605 |
| 40 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.58430164 |
| 41 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56552965 |
| 42 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.55431122 |
| 43 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.54366755 |
| 44 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.50178117 |
| 45 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.49687809 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.48664822 |
| 47 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47822091 |
| 48 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.46188222 |
| 49 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.45962415 |
| 50 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.45937232 |
| 51 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.41971267 |
| 52 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.40711547 |
| 53 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.33592025 |
| 54 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32607184 |
| 55 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.32073290 |
| 56 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.31211686 |
| 57 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30978513 |
| 58 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.28478394 |
| 59 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.27200943 |
| 60 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.25827350 |
| 61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25542797 |
| 62 | * MYC_18940864_ChIP-ChIP_HL60_Human | 1.24622384 |
| 63 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.23667105 |
| 64 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22526424 |
| 65 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.21877295 |
| 66 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20348311 |
| 67 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.10588789 |
| 68 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.09105769 |
| 69 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.08553014 |
| 70 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.08421945 |
| 71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.07668826 |
| 72 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04841213 |
| 73 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.03147388 |
| 74 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.01256188 |
| 75 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.99298881 |
| 76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98361239 |
| 77 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.98019660 |
| 78 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.95992677 |
| 79 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.95936234 |
| 80 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.95328719 |
| 81 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95036603 |
| 82 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.94575749 |
| 83 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94557719 |
| 84 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93967541 |
| 85 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93173837 |
| 86 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.92911164 |
| 87 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.92683819 |
| 88 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.91404958 |
| 89 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.91266920 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90189906 |
| 91 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.90020439 |
| 92 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.89888015 |
| 93 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.87718952 |
| 94 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.87599955 |
| 95 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.86306099 |
| 96 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.86152995 |
| 97 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.85881516 |
| 98 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.85258760 |
| 99 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.81869809 |
| 100 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.81618258 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002102_abnormal_ear_morphology | 4.25448173 |
| 2 | MP0010030_abnormal_orbit_morphology | 4.19776452 |
| 3 | MP0008058_abnormal_DNA_repair | 3.12187314 |
| 4 | MP0003693_abnormal_embryo_hatching | 2.80798402 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 2.51176758 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 2.35325400 |
| 7 | MP0001905_abnormal_dopamine_level | 2.33737731 |
| 8 | MP0001529_abnormal_vocalization | 2.32083411 |
| 9 | MP0006036_abnormal_mitochondrial_physio | 2.31868300 |
| 10 | MP0003186_abnormal_redox_activity | 2.28523353 |
| 11 | MP0003786_premature_aging | 2.13139290 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.01082697 |
| 13 | MP0006035_abnormal_mitochondrial_morpho | 2.00675525 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.00375442 |
| 15 | MP0008789_abnormal_olfactory_epithelium | 1.99674708 |
| 16 | MP0003111_abnormal_nucleus_morphology | 1.97527772 |
| 17 | MP0002234_abnormal_pharynx_morphology | 1.96455217 |
| 18 | MP0008007_abnormal_cellular_replicative | 1.95815941 |
| 19 | MP0002938_white_spotting | 1.94107024 |
| 20 | MP0003880_abnormal_central_pattern | 1.84247748 |
| 21 | MP0005394_taste/olfaction_phenotype | 1.83966238 |
| 22 | MP0005499_abnormal_olfactory_system | 1.83966238 |
| 23 | MP0003718_maternal_effect | 1.83764051 |
| 24 | MP0010094_abnormal_chromosome_stability | 1.79361544 |
| 25 | MP0002822_catalepsy | 1.77347762 |
| 26 | MP0003077_abnormal_cell_cycle | 1.75053759 |
| 27 | MP0010386_abnormal_urinary_bladder | 1.72340683 |
| 28 | MP0003136_yellow_coat_color | 1.68972995 |
| 29 | MP0000372_irregular_coat_pigmentation | 1.63668912 |
| 30 | MP0000049_abnormal_middle_ear | 1.56181535 |
| 31 | MP0002736_abnormal_nociception_after | 1.52724447 |
| 32 | MP0000015_abnormal_ear_pigmentation | 1.50805087 |
| 33 | MP0006292_abnormal_olfactory_placode | 1.47309181 |
| 34 | MP0003315_abnormal_perineum_morphology | 1.45528306 |
| 35 | MP0001764_abnormal_homeostasis | 1.41983869 |
| 36 | MP0005075_abnormal_melanosome_morpholog | 1.40638841 |
| 37 | MP0001188_hyperpigmentation | 1.38738809 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.36035647 |
| 39 | MP0003123_paternal_imprinting | 1.32146322 |
| 40 | MP0004133_heterotaxia | 1.31330283 |
| 41 | MP0002277_abnormal_respiratory_mucosa | 1.29287672 |
| 42 | MP0005410_abnormal_fertilization | 1.23249038 |
| 43 | MP0006072_abnormal_retinal_apoptosis | 1.20750183 |
| 44 | MP0002210_abnormal_sex_determination | 1.19874132 |
| 45 | MP0001929_abnormal_gametogenesis | 1.18571457 |
| 46 | MP0000538_abnormal_urinary_bladder | 1.17179899 |
| 47 | MP0000358_abnormal_cell_content/ | 1.16452185 |
| 48 | MP0002233_abnormal_nose_morphology | 1.16076040 |
| 49 | MP0005083_abnormal_biliary_tract | 1.13916661 |
| 50 | MP0003938_abnormal_ear_development | 1.10882797 |
| 51 | MP0001293_anophthalmia | 1.09180871 |
| 52 | MP0003698_abnormal_male_reproductive | 1.08474574 |
| 53 | MP0001145_abnormal_male_reproductive | 1.05613372 |
| 54 | MP0000653_abnormal_sex_gland | 1.00979765 |
| 55 | MP0000749_muscle_degeneration | 0.99845169 |
| 56 | MP0009745_abnormal_behavioral_response | 0.99421966 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 0.98903114 |
| 58 | MP0000750_abnormal_muscle_regeneration | 0.98828112 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 0.97853632 |
| 60 | MP0002751_abnormal_autonomic_nervous | 0.94496914 |
| 61 | MP0005174_abnormal_tail_pigmentation | 0.93879907 |
| 62 | MP0002132_abnormal_respiratory_system | 0.92747619 |
| 63 | MP0006276_abnormal_autonomic_nervous | 0.92171482 |
| 64 | MP0005501_abnormal_skin_physiology | 0.90999531 |
| 65 | MP0002653_abnormal_ependyma_morphology | 0.89327668 |
| 66 | MP0009379_abnormal_foot_pigmentation | 0.88981827 |
| 67 | MP0009046_muscle_twitch | 0.88899755 |
| 68 | MP0001984_abnormal_olfaction | 0.88485343 |
| 69 | MP0002160_abnormal_reproductive_system | 0.88046023 |
| 70 | MP0001919_abnormal_reproductive_system | 0.87515041 |
| 71 | MP0003011_delayed_dark_adaptation | 0.87397904 |
| 72 | MP0000313_abnormal_cell_death | 0.82291499 |
| 73 | MP0005367_renal/urinary_system_phenotyp | 0.81814977 |
| 74 | MP0000516_abnormal_urinary_system | 0.81814977 |
| 75 | MP0005171_absent_coat_pigmentation | 0.81279337 |
| 76 | MP0000537_abnormal_urethra_morphology | 0.81202722 |
| 77 | MP0002638_abnormal_pupillary_reflex | 0.80590156 |
| 78 | MP0003137_abnormal_impulse_conducting | 0.80403437 |
| 79 | MP0002177_abnormal_outer_ear | 0.80346493 |
| 80 | MP0003119_abnormal_digestive_system | 0.79715724 |
| 81 | MP0003937_abnormal_limbs/digits/tail_de | 0.78442102 |
| 82 | MP0002249_abnormal_larynx_morphology | 0.77004080 |
| 83 | MP0002095_abnormal_skin_pigmentation | 0.74847886 |
| 84 | MP0002085_abnormal_embryonic_tissue | 0.74844720 |
| 85 | MP0002161_abnormal_fertility/fecundity | 0.73775916 |
| 86 | MP0005389_reproductive_system_phenotype | 0.73183438 |
| 87 | MP0008872_abnormal_physiological_respon | 0.71998875 |
| 88 | MP0002075_abnormal_coat/hair_pigmentati | 0.71923652 |
| 89 | MP0002163_abnormal_gland_morphology | 0.70500443 |
| 90 | MP0000371_diluted_coat_color | 0.69738810 |
| 91 | MP0002272_abnormal_nervous_system | 0.68368191 |
| 92 | MP0003567_abnormal_fetal_cardiomyocyte | 0.68325248 |
| 93 | MP0001697_abnormal_embryo_size | 0.68200620 |
| 94 | MP0000026_abnormal_inner_ear | 0.67913979 |
| 95 | MP0001346_abnormal_lacrimal_gland | 0.67342886 |
| 96 | MP0003755_abnormal_palate_morphology | 0.66719179 |
| 97 | MP0004270_analgesia | 0.65933599 |
| 98 | MP0001730_embryonic_growth_arrest | 0.65924275 |
| 99 | MP0002734_abnormal_mechanical_nocicepti | 0.65828701 |
| 100 | MP0002080_prenatal_lethality | 0.65135277 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.17317263 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.93798055 |
| 3 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.76288089 |
| 4 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.76288089 |
| 5 | Hepatocellular necrosis (HP:0001404) | 4.71890767 |
| 6 | Mitochondrial inheritance (HP:0001427) | 4.67816057 |
| 7 | Acute encephalopathy (HP:0006846) | 4.60521865 |
| 8 | Progressive macrocephaly (HP:0004481) | 4.24354074 |
| 9 | Increased CSF lactate (HP:0002490) | 4.16520471 |
| 10 | Hepatic necrosis (HP:0002605) | 3.94140770 |
| 11 | Increased hepatocellular lipid droplets (HP:0006565) | 3.79067685 |
| 12 | Renal Fanconi syndrome (HP:0001994) | 3.64131541 |
| 13 | Lipid accumulation in hepatocytes (HP:0006561) | 3.52837212 |
| 14 | Lactic acidosis (HP:0003128) | 3.33543961 |
| 15 | Reduced antithrombin III activity (HP:0001976) | 3.27242476 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 3.26318868 |
| 17 | Cerebral hypomyelination (HP:0006808) | 3.26296123 |
| 18 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.25063341 |
| 19 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.25063341 |
| 20 | Abnormal protein glycosylation (HP:0012346) | 3.25063341 |
| 21 | Abnormal glycosylation (HP:0012345) | 3.25063341 |
| 22 | Cerebral edema (HP:0002181) | 3.23411780 |
| 23 | Increased serum lactate (HP:0002151) | 3.16939181 |
| 24 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.12211287 |
| 25 | Type I transferrin isoform profile (HP:0003642) | 3.11772314 |
| 26 | Exercise intolerance (HP:0003546) | 3.06830704 |
| 27 | Hypokinesia (HP:0002375) | 2.91812926 |
| 28 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.90765510 |
| 29 | Microvesicular hepatic steatosis (HP:0001414) | 2.82430127 |
| 30 | Increased muscle lipid content (HP:0009058) | 2.79607062 |
| 31 | 3-Methylglutaconic aciduria (HP:0003535) | 2.70645908 |
| 32 | Abnormality of glycolysis (HP:0004366) | 2.66102327 |
| 33 | Respiratory failure (HP:0002878) | 2.64837070 |
| 34 | Colon cancer (HP:0003003) | 2.61914513 |
| 35 | Abnormal number of erythroid precursors (HP:0012131) | 2.59870519 |
| 36 | Hypoglycemic seizures (HP:0002173) | 2.53885428 |
| 37 | Testicular atrophy (HP:0000029) | 2.53728874 |
| 38 | Abnormality of the anterior horn cell (HP:0006802) | 2.49048384 |
| 39 | Degeneration of anterior horn cells (HP:0002398) | 2.49048384 |
| 40 | Microretrognathia (HP:0000308) | 2.44997182 |
| 41 | Increased serum pyruvate (HP:0003542) | 2.38505812 |
| 42 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.35340396 |
| 43 | Leukodystrophy (HP:0002415) | 2.25182546 |
| 44 | Lethargy (HP:0001254) | 2.22127861 |
| 45 | Emotional lability (HP:0000712) | 2.18970040 |
| 46 | Exertional dyspnea (HP:0002875) | 2.18911460 |
| 47 | Rough bone trabeculation (HP:0100670) | 2.18013451 |
| 48 | Respiratory difficulties (HP:0002880) | 2.17628592 |
| 49 | Entropion (HP:0000621) | 2.16572950 |
| 50 | CNS demyelination (HP:0007305) | 2.16165031 |
| 51 | Abnormality of the labia minora (HP:0012880) | 2.14374818 |
| 52 | Double outlet right ventricle (HP:0001719) | 2.13378021 |
| 53 | Congenital malformation of the right heart (HP:0011723) | 2.13378021 |
| 54 | Opisthotonus (HP:0002179) | 2.11266123 |
| 55 | Optic disc pallor (HP:0000543) | 2.11086648 |
| 56 | Cholecystitis (HP:0001082) | 2.08707395 |
| 57 | Abnormal gallbladder physiology (HP:0012438) | 2.08707395 |
| 58 | Poikiloderma (HP:0001029) | 2.08106184 |
| 59 | Unsteady gait (HP:0002317) | 2.05244062 |
| 60 | Macrocytic anemia (HP:0001972) | 2.04923292 |
| 61 | X-linked dominant inheritance (HP:0001423) | 2.03238082 |
| 62 | Postnatal microcephaly (HP:0005484) | 2.03035662 |
| 63 | Horseshoe kidney (HP:0000085) | 2.01509622 |
| 64 | CNS hypomyelination (HP:0003429) | 2.01292627 |
| 65 | Limb dystonia (HP:0002451) | 1.96800110 |
| 66 | Reticulocytopenia (HP:0001896) | 1.94400146 |
| 67 | Poor suck (HP:0002033) | 1.94224023 |
| 68 | Prominent metopic ridge (HP:0005487) | 1.93089307 |
| 69 | Aplastic anemia (HP:0001915) | 1.92845737 |
| 70 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.89198049 |
| 71 | Abnormality of renal resorption (HP:0011038) | 1.88665379 |
| 72 | Hypoplasia of the uterus (HP:0000013) | 1.87503793 |
| 73 | Retinal dysplasia (HP:0007973) | 1.86826922 |
| 74 | Myokymia (HP:0002411) | 1.85847269 |
| 75 | Symptomatic seizures (HP:0011145) | 1.84138679 |
| 76 | Progressive microcephaly (HP:0000253) | 1.81728909 |
| 77 | Sclerocornea (HP:0000647) | 1.81450535 |
| 78 | Abnormal lung lobation (HP:0002101) | 1.80106433 |
| 79 | Pancreatic fibrosis (HP:0100732) | 1.79354898 |
| 80 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.79154416 |
| 81 | Methylmalonic aciduria (HP:0012120) | 1.78750254 |
| 82 | Secondary amenorrhea (HP:0000869) | 1.78353194 |
| 83 | Squamous cell carcinoma (HP:0002860) | 1.77748738 |
| 84 | Median cleft lip (HP:0000161) | 1.77629928 |
| 85 | Gout (HP:0001997) | 1.76059064 |
| 86 | Abnormality of the metopic suture (HP:0005556) | 1.75115286 |
| 87 | Medial flaring of the eyebrow (HP:0010747) | 1.73206789 |
| 88 | Hyperglycinemia (HP:0002154) | 1.72661895 |
| 89 | Neoplasm of the adrenal gland (HP:0100631) | 1.68913926 |
| 90 | Muscle fiber atrophy (HP:0100295) | 1.68535462 |
| 91 | Facial cleft (HP:0002006) | 1.68262856 |
| 92 | Preaxial hand polydactyly (HP:0001177) | 1.68244168 |
| 93 | Pancytopenia (HP:0001876) | 1.67719529 |
| 94 | Abnormal trabecular bone morphology (HP:0100671) | 1.66368709 |
| 95 | Blindness (HP:0000618) | 1.64180876 |
| 96 | Diminished movement (HP:0002374) | 1.63826532 |
| 97 | Delusions (HP:0000746) | 1.63588880 |
| 98 | Hypoplastic left heart (HP:0004383) | 1.59621672 |
| 99 | Sensory axonal neuropathy (HP:0003390) | 1.57453542 |
| 100 | Type 2 muscle fiber atrophy (HP:0003554) | 1.57186139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.36396239 |
| 2 | BUB1 | 4.15361838 |
| 3 | NME2 | 3.27942307 |
| 4 | STK16 | 3.10717296 |
| 5 | BCKDK | 2.38358377 |
| 6 | TLK1 | 2.33367146 |
| 7 | TAF1 | 2.21378784 |
| 8 | PBK | 2.15576011 |
| 9 | MAP4K2 | 2.10554306 |
| 10 | NEK1 | 2.06773976 |
| 11 | CSNK1G3 | 2.06678604 |
| 12 | VRK1 | 1.96144374 |
| 13 | SRPK1 | 1.93101084 |
| 14 | PINK1 | 1.92551328 |
| 15 | NUAK1 | 1.90857834 |
| 16 | TESK1 | 1.89673636 |
| 17 | ZAK | 1.85407030 |
| 18 | CDK19 | 1.77869650 |
| 19 | NME1 | 1.75042903 |
| 20 | CSNK1G1 | 1.72796013 |
| 21 | MUSK | 1.71035176 |
| 22 | TRIM28 | 1.69685632 |
| 23 | PRKD3 | 1.69294811 |
| 24 | CSNK1G2 | 1.60820289 |
| 25 | EIF2AK1 | 1.57787222 |
| 26 | LIMK1 | 1.52282089 |
| 27 | MAP2K7 | 1.49601564 |
| 28 | TSSK6 | 1.45321891 |
| 29 | CSNK1A1L | 1.44397965 |
| 30 | SMG1 | 1.42031413 |
| 31 | ABL2 | 1.36622914 |
| 32 | PLK3 | 1.36015103 |
| 33 | DYRK2 | 1.35340440 |
| 34 | ILK | 1.24479859 |
| 35 | DAPK1 | 1.24157719 |
| 36 | BMPR1B | 1.17077799 |
| 37 | CDC7 | 1.16302758 |
| 38 | EIF2AK3 | 1.11267036 |
| 39 | PDK2 | 1.07036775 |
| 40 | TESK2 | 1.06657806 |
| 41 | ARAF | 1.06338802 |
| 42 | DAPK3 | 1.05112011 |
| 43 | PLK1 | 1.01707612 |
| 44 | GRK5 | 1.01662329 |
| 45 | BRSK1 | 1.01359829 |
| 46 | PIM2 | 0.98647388 |
| 47 | AURKA | 0.95905322 |
| 48 | LMTK2 | 0.90888741 |
| 49 | WNK3 | 0.83729111 |
| 50 | SIK3 | 0.82854689 |
| 51 | EPHA4 | 0.79733037 |
| 52 | MST4 | 0.79431571 |
| 53 | TTK | 0.79028962 |
| 54 | DYRK3 | 0.78536083 |
| 55 | PAK4 | 0.77995343 |
| 56 | PAK1 | 0.77009317 |
| 57 | WEE1 | 0.76980696 |
| 58 | AURKB | 0.74783837 |
| 59 | GRK1 | 0.71187225 |
| 60 | MAPKAPK5 | 0.69242789 |
| 61 | CHEK2 | 0.68521915 |
| 62 | RPS6KA5 | 0.68344948 |
| 63 | KDR | 0.66834793 |
| 64 | CDK14 | 0.65846477 |
| 65 | PASK | 0.64946155 |
| 66 | MARK3 | 0.62758332 |
| 67 | PRKCI | 0.61303532 |
| 68 | EPHA2 | 0.61202647 |
| 69 | ATR | 0.60530502 |
| 70 | ADRBK2 | 0.59854234 |
| 71 | BRAF | 0.58626030 |
| 72 | CDK11A | 0.56771063 |
| 73 | CDK7 | 0.56199083 |
| 74 | CDK18 | 0.55663212 |
| 75 | MAP3K12 | 0.55231272 |
| 76 | CSNK2A1 | 0.53043654 |
| 77 | CAMK2G | 0.52522888 |
| 78 | AKT2 | 0.52296864 |
| 79 | CDK15 | 0.52119103 |
| 80 | CDK8 | 0.50524434 |
| 81 | CSNK2A2 | 0.49148293 |
| 82 | TXK | 0.48323438 |
| 83 | MINK1 | 0.46726573 |
| 84 | PRKCG | 0.45948592 |
| 85 | IRAK2 | 0.45636091 |
| 86 | CDK9 | 0.45082751 |
| 87 | STK4 | 0.41982634 |
| 88 | TAOK2 | 0.41519471 |
| 89 | MAP3K11 | 0.41034902 |
| 90 | CSNK1A1 | 0.39870077 |
| 91 | MAPKAPK3 | 0.39397578 |
| 92 | PRKD2 | 0.39120418 |
| 93 | CAMK2D | 0.38391700 |
| 94 | NTRK3 | 0.37434860 |
| 95 | OXSR1 | 0.33198816 |
| 96 | CAMK2B | 0.33167704 |
| 97 | CHEK1 | 0.32877002 |
| 98 | PAK6 | 0.32635279 |
| 99 | MAPK13 | 0.31460300 |
| 100 | PLK2 | 0.30776780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.66441726 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.60198514 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.43656265 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.09523433 |
| 5 | Sulfur relay system_Homo sapiens_hsa04122 | 2.94244701 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.58198274 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.51226861 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.38805734 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.36790574 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.35896337 |
| 11 | Huntingtons disease_Homo sapiens_hsa05016 | 2.17554916 |
| 12 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.95010021 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 1.94820907 |
| 14 | Protein export_Homo sapiens_hsa03060 | 1.88772541 |
| 15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.87812867 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.86281163 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.84118820 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.68748828 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.63361346 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.62027539 |
| 21 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.58148095 |
| 22 | Spliceosome_Homo sapiens_hsa03040 | 1.57082787 |
| 23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.56774443 |
| 24 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.56010096 |
| 25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.54551891 |
| 26 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.50572489 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.49820594 |
| 28 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.48413232 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.48407916 |
| 30 | RNA transport_Homo sapiens_hsa03013 | 1.45592122 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45521060 |
| 32 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.42683571 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.40893261 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.39374968 |
| 35 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.36826530 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.29154944 |
| 37 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29064399 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.28439544 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.27234902 |
| 40 | Purine metabolism_Homo sapiens_hsa00230 | 1.25380072 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.24689517 |
| 42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15419550 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.11094336 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06958639 |
| 45 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06172450 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.05610645 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 1.01168001 |
| 48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.98553797 |
| 49 | Metabolic pathways_Homo sapiens_hsa01100 | 0.93244533 |
| 50 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.88822057 |
| 51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.88424394 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.85084002 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.83187315 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82911090 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79447882 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.78487523 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77290143 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76264704 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76011669 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.75102741 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 0.72213728 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.71620862 |
| 63 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.71397065 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.71301403 |
| 65 | Cell cycle_Homo sapiens_hsa04110 | 0.71158387 |
| 66 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62543223 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59749290 |
| 68 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55310194 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.51739426 |
| 70 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.50319284 |
| 71 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.49563545 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.49177135 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48994167 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47786660 |
| 75 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47624586 |
| 76 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.46498551 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45178696 |
| 78 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.39122049 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38389511 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34785153 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34704054 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.33709454 |
| 83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.32245602 |
| 84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.30465427 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.29906341 |
| 86 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.29308477 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.28693077 |
| 88 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28441085 |
| 89 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.27072301 |
| 90 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26181484 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.24839354 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.23678651 |
| 93 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.23440619 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21719016 |
| 95 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.19552107 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.17850791 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.17342617 |
| 98 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.16477210 |
| 99 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.13211075 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.12841965 |

